Non-Hodgkin's lymphoma involving the liver: Clinical and therapeutic considerations

Clinical Lymphoma and Myeloma

Volumn 6, Issue 4, 2006, Pages 273-280

  Salmon, J Stuart ^a   Thompson, Mary Ann ^a   Arildsen, Ronald C ^a   Greer, John P ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Hepatic insufficiency; Hepatic metabolism; Hepatitis C; Hepatosplenic T cell lymphoma; Immunophenotypes

Indexed keywords

ACROLEIN; ALDOPHOSPHAMIDE; ANTHRACYCLINE DERIVATIVE; CHLORMETHINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUDARABINE; PENTOSTATIN; PHOSPHORAMIDIC ACID; PLATINUM; PLATINUM COMPLEX; PLATINUM DERIVATIVE; PREDNISONE; RITUXIMAB; VINCA ALKALOID; VINCRISTINE;

ANAPLASTIC CARCINOMA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; BURKITT LYMPHOMA; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC HEPATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXICITY; DISEASE ASSOCIATION; DOSE LIVER FUNCTION RELATION; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EXCRETION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; ECHOGRAPHY; FOLLICULAR LYMPHOMA; HEPATITIS C; HEPATITIS NON A NON B; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; IN VITRO STUDY; INCIDENCE; ISOCHROMOSOME; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER GRAFT; LIVER METABOLISM; LIVER METASTASIS; LIVER TUMOR; LYMPHATIC LEUKEMIA; LYMPHOCYTOMA; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEUROTOXICITY; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PERIPHERAL T CELL LYMPHOMA; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TRISOMY 8; VIRUS HEPATITIS; LIVER FAILURE; METASTASIS; PATHOLOGY; REVIEW; SPLEEN TUMOR; T CELL LYMPHOMA;

HEPATITIS C; HUMANS; LIVER FAILURE; LIVER NEOPLASMS; LYMPHOMA, T-CELL; SPLENIC NEOPLASMS;

EID: 33645061810     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2006.n.001     Document Type: Review

References (92)

1. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) database. Bethesda, MD: National Cancer Institute, 2002. Available at: http://seer.cancer.gov/faststats/html/inc_nhl.html. Accessed May 1, 2005.
2. Caccamo D, Pervez NK, Marchevsky A. Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1986; 110:553-555.
3. Lei KI, Chow JH, Johnson PJ. Aggressive primary hepatic lymphoma in Chinese patients: presentation, pathologic features, and outcome. Cancer 1995; 76:1336-1343.
4. Osborne BM, Butler JJ, Guarda LA. Primary lymphoma of the liver. Cancer 1985; 56:2902-2910.
5. Anthony PP, Sarsfield P, Clarke T. Primary lymphoma of the liver: clinical and pathological features of 10 patients. J Clin Pathol 1990; 43:1007-1013.
6. Scoazec JY, Degott C, Brousse N, et al. Non-Hodgki's lymphoma presenting as a primary tumor of the liver: presentation, diagnosis, and outcome in eight patients. Hepatalogy 1991; 13:870-875.
7. Bagley CM Jr, Thomas LB, Johnson RE, et al. Diagnosis of liver involvement by lymphoma: results in 96 consecutive peritoneoscopies. Cancer 1973; 31:840-847.
8. Castellani R, Bonadonna G, Spinelli P, et al. Sequential pathologic staging of untreated non-Hodgkin's lymphomas by laparoscopy and laparotomy combined with marrow biopsy. Cancer 1977; 40:2322-2328.
9. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29:252-260.
10. Otter R, Gerritis WB, Sandt MM, et al. Primary extranodal and nodal non-Hodgkin's lymphoma: a survey of a population-based registry. Eur J Cancer Clin Oncol 1989; 25:1203-1210.
11. Lei KI. Primary non-Hodgkin's lymphoma of the liver. Leuk Lymphoma 1998; 29:293-299.
12. Avlonitis VS, Linos D. Primary hepatic lymphoma: a review. Eur J Surg 1999; 165:725-729.
13. Lettieri CJ, Berg BW. Clinical features of non-Hodgkin's lymphoma presenting with acute liver failure: a report of five cases and review of the published experience. Am J Gastroenterol 2003; 98:1641-1646.
14. Gosh P, Fox I, Rader A, et al. Fulminant hepatic failure as the initial manifestation of non-Hodgkin's lymphoma. Am J Gastroenterol 1995; 90:2207-2209.
15. Zafrani E, Leclercq B, Vernant JP, et al. Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatologv 1983; 3:428-432.
16. Braude S, Portmann B, Gimson A, et al. Fulminant hepatic failure in non-Hodgkin's lymphoma. Postgrad Med J 1982; 58:301-304.
17. Trewby P, Portmann B, Brinkley D, et al. Liver disease as the presenting manifestation of Hodgkin's disease. Q J Med 1979; 189:137-150.
18. Thompson D, Faust T, Stone M, et al. Hepatic failure as the presenting manifestation of malignant lymphoma. Clin Lymphoma 2001; 2:123-128.
19. Das A, Bhusnumath S, Snood G, et al. Primary hepatic lymphoma mimicking fulminant hepatic failure. Ind J Gastroenterol 1993; 12:147-148.
20. Chambers T, O'Donoghue D, Stansfeld A. A case of primary lymphoma of the liver. J Clin Pathol 1976; 29:967-970.
21. Woolf G, Petrovic L, Rojter S, et al. Acute liver failure due to lymphoma. Dig Dis Sci 1994; 39:1351-1358.
22. Colby T, LaBrecque D. Lymphoreticular malignancy presenting as fulminant hepatic disease. Gastroenterology 1982; 82:339-345.
23. Salo C, Nomdedeu B, Bruguera M, et al. Acute liver failure due to non-Hodgkin's lymphoma. Am J Gastroenterol 1993; 88:774-776.
24. Blakolmer K, Gaulard P, Mannhalter C, et al. Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft. Transplantation 2000; 70:1802-1805.
25. Suzuki N, Tsuji H, Nakamura S, et al. An autopsy case of Ki-1 lymphoma associated with hepatic failure. Am J Gostroenterol 1998; 93:115-117.
26. Aghai E, Quitt M, Lurie M, et al. Primary hepatic lymphoma presenting as symptomatic immune thrombocytopenic purpura. Cancer 1987; 60:2308-2311.
27. Santhosh-Kumar CR, Ajarim DSS, et al. Primary non-Hodgkin's lymphoma or liver with humoral hypercalcaemia. Postgrad Med J 1990; 66:679-681.
28. Borgonovo G, D'Oiron R, Amato A, et al. Primary lymphoplasmacytic lymphoma of the liver associated with a serum monoclonal peak of IgG kappa. Am J Gastroenterol 1995; 90:137-140.
29. Isaacson PG, Banks PM, Best PV, et al. Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type. Am J Surg Pathol 1995; 19:571-575.
30. Leahy MF, Ibrahim EM, Worth AJ. Primary hepatic lymphoma: two case reports and a review of the literature. Med Pediatr Oncol 1982; 10:575-581.
31. Bronowicki JP, Bineau C, Feugier P, et al. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 2003; 37:781-787.
32. Das K, Fisher A, Wilson DJ, et al. Primary non-Hodgkin's lymphoma of the bile ducts mimicking cholangiocarcinoma. Surgery 2003; 134:496-500.
33. Rizzi EB, Schinina V, Cristofaro M, et al. Non-Hodgkin's lymphoma of the liver in patients with AIDS: sonographic, CT, and MRI findings. J Clin Ultrasound 2001; 29:125-129.
34. Harisinghani MG, Hahn PF. Computed tomography and magnetic resonance imaging evaluation of liver cancer. Gastroenterol Clin 2002; 31:759-776.
35. Bartolozzi C, Cioni D, Donati F, et al. Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 2001; 11: 1374-1388.
36. Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [I8F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001; 19:414-419.
37. Khan SM, Cottrell BJ, Millward-Sadler GH, et al. T-cell-rich B-cell lymphoma presenting as liver disease. Histopathology 1993; 23:217-224.
38. Kuroda J, Omoto A, Fujiki H, et al. Primary hepatic Burkitt's lymphoma with chronic hepatitis C. Acta Haematol 2001; 105:237-240.
39. Chim CS, Choy C, Ooi GC, et al. Primary hepatic lymphoma. Leuk Lymphoma 2001; 40:667-670.
40. Huang CB, Eng HL, Chuang JH, et al. Primary Burkitt's lymphoma of the liver: report of a case with long-term survival after surgical resection and combination chemotherapy. J Pediatr Hematol Oncol 1997; 19:135-138.
41. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 1998; 12:1281-1287.
42. Yago K, Shimada H, Itoh M, et al. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type of the liver in a patient with hepatitis C virus infection. Leuk Lymphoma 2002; 43:1497-1500.
43. Murakami J, Fukushima N, Ueno H, et al. Primary hepatic low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue type: a case report and review of the literature. Int J Hematol 2002; 75:85-90.
44. Ye MQ, Suriawinata A, Black C, et al. Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch Pathol Lab Med 2000; 124:604-608.
45. Kirk CM, Lewin D, Lazarchick J. Primary hepatic B-cell lymphoma of mucosa-associated lymphoid tissue. Arch Pathol Lab Med 1999; 123:716-719.
46. Prabhu RM, Medeiros LJ, Kumar D, et al. Primary hepatic low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis. Mod Pathol 1998; 11:404-410.
47. Maes M, Depardieu C, Dargent JL, et al. Primary low-grade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases. J Hepatol 1997; 27:922-927.
48. Torres A. Primary lymphocytic follicular lymphoma of liver. Cancer 1969; 23:1185-1189.
49. Matano S, Nakamura S, Annen Y, et al. Primary hepatic lymphoma in a patient with chronic hepatitis B. Am J Gastroenterol 1998; 93:2301-2302.
50. Ohsawa M, Aozasa K, Horiuchi K, et al. Malignant lymphoma of the liver. Report of five cases and review of the literature. Dig Dis Sci 1992,37:1105-1109.
51. Baschinsky DY, Weidner N, Baker PB, et al. Primary hepatic anaplastic large-cell lymphoma of T-phenotype in acquired immunodeficiency syndrome: a report of an autopsy case and review of the literature. Am J Gastroenterol 2001; 96:227-232.
52. Mitarnun W, Kietthubthew S, Suwiwat S. Hepatic peripheral T cell lymphoma: a spectrum of liver pathology and clinical correlation. J Med Assoc Thai 1997; 80:219-232.
53. Stancu M, Jones D, Vega F, et al. Peripheral T-cell lymphoma arising in the liver. Am J Clin Pathol 2002; 118:574-581.
54. Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102:4261-4269.
55. Weidmann E. Hepatosplenic T-cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000; 14:991-997.
56. Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103:2474-2479.
57. Stein H, Foss HD, Dürkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96:3681-3695.
58. Tilly H, Gaulard P, Lepage E, et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotypes, and outcome. Blood 1997; 90:3727-3734.
59. Brugieres L, Le Deley MC, Pacquement H, et al. CD30+ anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 1998; 92:3591-3598.
60. Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol 2001; 25:285-296.
61. Alonsozana ELC, Sramberg J, Kumar D, et al. Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma. Leukemia 1997; 11:1367-1393.
62. Golli L, Taieb J, Boleslawski E, et al. Mucosa-associated lymphoid tissue hepatic lymphoma with low-grade malignancy associated with primary biliary cirrhosis. Gastroenterol Clin Biol 2003; 27:127-129.
63. Sato S, Masuda T, Oikawa H, et al. Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol 1999; 94:1669-1673.
64. Goldin R, Sayer J, Wilkins M, et al. Primary liver lymphoma associated with primary biliary cirrhosis. Histopathology 1993; 22:184-185.
65. Matano S, Nakamura S, Annen Y, et al. Primary hepatic lymphoma in a patient with chronic hepatitis B. Am J Gastroenterol 1998; 93:2301-2302.
66. Lisker-Melman M, Pittaluga S, Pluda JM, et al. Primary lymphoma of the liver in a patient with acquired immune deficiency syndrome and chronic hepatitis B. Am J Gastroenterol 1989; 84:1445-1448.
67. Talamo TS, Dekker A, Gurecki J, et al. Primary hepatic malignant lymphoma: its occurrence in a patient with chronic active hepatitis, cirrhosis, and hepatocellular carcinoma associated with hepatitis B viral infection. Cancer 1980; 46:336-339.
68. Sutton E, Malatjalian D, Hayne OA, et al. Liver lymphoma in systemic lupus erythematosis.J Rheumatol 1989; 16:1584-1588.
69. Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma 2003; 44:1113-1120.
70. Kitabayashi K, Hasegawa T, Ueno K, et al. Primary hepatic non-Hodgkin's lymphoma in a patient with chronic hepatitis C: report of a case. Surg Today 2004; 34:366-369.
71. Genvresse I, Späth-Schwalbe E, Meisel H, et al. Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association? Ann Hematol 2000; 79:530-532.
72. Kim JH, Kim HY, Kang I, et al. A case of primary hepatic lymphoma with hepatitis liver cirrhosis. Am J Gastroenterol 2000; 95:2377-2380.
73. Page RD, Romaguera JE, Osborne B, et al. Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer 2001; 92:2023-2029.
74. De Vita S, Sacco C, Sansonno D, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90:776-782.
75. Quinn ER, Chan CH, Hadlock KG, et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin's lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98:3745-3749.
76. Bauduer F, Marty F, Gemain MC, et al. Primary non-Hodgkin's lymphoma of the liver in a patient with hepatitis B, C and HIV infections. Am J Hematol 1997; 54:265.
77. Honda H, Franken EA, Barloon TJ, et al. Hepatic lymphoma in cyclosporine-treated transplant recipients: sonographic and CT findings. AJR Am J RoentgenoI 1989; 152:501-503.
78. Palazzo JP, Lundquist K, Mitchell D, et al. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemachromatosis. Am J Gastroenterol 1993; 88:102-104.
79. Rostaing L, Suc B, Fourtanier G, et al. Liver B-cell lymphoma after liver transplantation. Transplant Proc 1995; 88:677-680.
80. Kruger A, Umansky V, Rocha M, et al. Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 1994; 84:3166-3174.
81. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329:987-994.
82. Lee EJ, Petroni GR, Schiffer CA, et al. Brief-duration high-intensity chemotherapy for patients with small non-cleaved cell lymphoma or FAB L3 lymphocytic leukemia: results of CALGB 9251. J Clin Oncol 2001; 19:4014-4022.
83. Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group trial NHL-BFM 90. Blood 2001; 97:3699-3705.
84. Cabanillas F, Rodriguez-Diaz PJ, Hagemeister FB, et al. Alternating triple therapy for the treatment of intermediate grade and inummoblastic lymphoma. Ann Oncol 1998; 9:511-518.
85. Aldinucci D, Poletto D, Zagonel V, et al. In vitro and in vivo effects of 2′-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies. Br J Haematol 2000; 110:188-196.
86. Grigg AP. 2′-deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma. Leuk Lymphoma 2001; 42:797-799.
87. Iannitto E, Barbera V, Quintini G, et al. Hepatosplenic γδ T-cell lymphoma: complete response induced by treatment with pentostatin. Br J Haematol 2002; 117:995-996.
88. Koren G, Beatty K, Seto A, et al. The effects of impaired liver function on the elimination of antineoplastic agents. Ann Pharmacother 1992; 26:363-371.
89. Johnson PJ, Dobbs N, Kalayci C, et al. Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters. Br J Cancer 1992; 65:751-755.
90. Van den Berg HW, Desai ZR, Wilson R, et al. The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination. Cancer Chemother Pharmacol 1982; 8:215-219.
91. Juma FD. Effect of liver failure on the pharmacokinetics of cyclophosphamide. Eur J CLin Pharmacol 1984; 26:591-593.
92. Ghobrial IM, Wolf RC, Pereira DL, et al. Therapeutic options in patients with lymphoma and sever liver dysfunction. Mayo Clin Proc 2004; 79:169-175.